Analysts’ Updated EPS Estimates for April 13th (AAPG, AMTM, ASML, AVTX, AXON, BLTE, BNTX, CHWY, FORM, GOOGL)

Analysts’ updated eps estimates for Monday, April 13th:

Ascentage Pharma Group International (NASDAQ:AAPG) had its buy rating reiterated by analysts at BTIG Research. They currently have a $48.00 price target on the stock.

Amentum (NYSE:AMTM) had its market outperform rating reaffirmed by analysts at Citizens Jmp. Citizens Jmp currently has a $40.00 target price on the stock.

ASML (NASDAQ:ASML) had its buy rating reaffirmed by analysts at JPMorgan Chase & Co..

Avalo Therapeutics (NASDAQ:AVTX) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $40.00 price target on the stock.

Axon Enterprise (NASDAQ:AXON) had its market outperform rating reaffirmed by analysts at Citizens Jmp. The firm currently has a $825.00 price target on the stock.

Belite Bio (NASDAQ:BLTE) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $200.00 target price on the stock.

BioNTech (NASDAQ:BNTX) had its buy rating reissued by analysts at Berenberg Bank.

Chewy (NYSE:CHWY) had its buy rating reiterated by analysts at Guggenheim. Guggenheim currently has a $45.00 price target on the stock.

FormFactor (NASDAQ:FORM) had its neutral rating reaffirmed by analysts at B. Riley Financial, Inc.. The firm currently has a $130.00 target price on the stock, up from their previous target price of $100.00.

Alphabet (NASDAQ:GOOGL) had its market outperform rating reissued by analysts at Citizens Jmp. The firm currently has a $385.00 price target on the stock.

GitLab (NASDAQ:GTLB) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $32.00 price target on the stock.

Halma (LON:HLMA) had its hold rating reaffirmed by analysts at Shore Capital Group Ltd.

Hewlett Packard Enterprise (NYSE:HPE) had its outperform rating reaffirmed by analysts at Raymond James Financial, Inc.. Raymond James Financial, Inc. currently has a $29.00 target price on the stock, down from their previous target price of $30.00.

HireQuest (NASDAQ:HQI) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $13.00 target price on the stock.

Hostelworld Group (LON:HSW) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 171 target price on the stock.

Marks Electrical Group (LON:MRK) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 55 price target on the stock.

Marks Electrical Group (LON:MRK) had its hold rating reiterated by analysts at Shore Capital Group Ltd.

M.T.I Wireless Edge (LON:MWE) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

NIKE (NYSE:NKE) had its neutral rating reiterated by analysts at JPMorgan Chase & Co..

NIKE (NYSE:NKE) had its hold rating reiterated by analysts at HSBC Holdings plc. The firm currently has a $48.00 target price on the stock, down from their previous target price of $90.00.

NXP Semiconductors (NASDAQ:NXPI) had its neutral rating reissued by analysts at Bank of America Corporation. Bank of America Corporation currently has a $230.00 price target on the stock, down from their previous price target of $245.00.

Oruka Therapeutics (NASDAQ:ORKA) had its buy rating reaffirmed by analysts at Guggenheim. The firm currently has a $125.00 target price on the stock.

Oshkosh (NYSE:OSK) had its neutral rating reissued by analysts at Citigroup Inc.. They currently have a $170.00 price target on the stock, down from their previous price target of $180.00.

Parsons (NYSE:PSN) had its neutral rating reiterated by analysts at Robert W. Baird. The firm currently has a $60.00 target price on the stock.

Roblox (NYSE:RBLX) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $122.00 price target on the stock.

Replimune Group (NASDAQ:REPL) had its neutral rating reissued by analysts at Cantor Fitzgerald.

Replimune Group (NASDAQ:REPL) had its sell rating reaffirmed by analysts at HC Wainwright.

Replimune Group (NASDAQ:REPL) had its underweight rating reissued by analysts at JPMorgan Chase & Co..

Replimune Group (NASDAQ:REPL) had its neutral rating reiterated by analysts at Wedbush. The firm currently has a $2.00 price target on the stock, down from their previous price target of $19.00.

Replimune Group (NASDAQ:REPL) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a $2.00 target price on the stock, down from their previous target price of $13.00.

Replimune Group (NASDAQ:REPL) had its market perform rating reiterated by analysts at Leerink Partners. The firm currently has a $2.00 price target on the stock, down from their previous price target of $11.00.

Secure Trust Bank (LON:STB) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd.

Thor Explorations (LON:THX) had its buy rating reaffirmed by analysts at Shore Capital Group Ltd.

Telix Pharmaceuticals (NASDAQ:TLX) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $20.00 price target on the stock.

Telix Pharmaceuticals (NASDAQ:TLX) had its outperform rating reiterated by analysts at Wedbush. They currently have a $22.00 price target on the stock.

Victrex (LON:VCT) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 725 target price on the stock.